Form EFFECT Quoin Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 4, 2025 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EMA grants orphan drug status to Quoin's QRX003 for skin disorder
- Ethereum Price Prediction: A $2,700 October Ceiling? AlphaPepe Makes Its Case for a Much Bigger Breakout
- Polygon Price Prediction: POL Trades Below $0.10 After TRON Payments Expansion as Remittix Builds Its PayFi Launch Case
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share